Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jan 31, 2026The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $44.66B | $338.06 | -2.52% | $151.92M | 1,090.52x | 19.74 | United States | 43 |
| LVS | LAS VEGAS SANDS CORP | NYSE | Resorts & Casinos | A | $35.65B | $52.73 | 0.04% | $4.05B | 23.86x | 12.50 | United States | 38 |
| PTC | PTC INC | NASDAQ | Software - Application | A | $18.65B | $156.13 | 1.73% | $1.13B | 25.51x | 0.73 | United States | 48 |
| THC | TENET HEALTHCARE CORP | NYSE | Medical Care Facilities | A | $16.63B | $189.28 | -0.11% | $3.48B | 12.77x | 5.16 | United States | 31 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | NASDAQ | Biotechnology | A | $10.00B | $164.49 | 0.31% | $182.64M | -27.46x | 1.87 | Ireland | 16 |
| PEGA | PEGASYSTEMS INC | NASDAQ | Software - Application | A | $7.42B | $43.69 | -2.08% | $373.32M | 26.97x | 1.17 | United States | 50 |
| VCYT | VERACYTE INC | NASDAQ | Biotechnology | A | $3.01B | $38.08 | -1.70% | $57.00M | 97.64x | 0.09 | United States | 45 |
| CALX | CALIX INC | NYSE | Software - Application | A | $2.96B | $44.67 | -4.26% | $10.21M | -446.70x | 0.19 | United States | 33 |
| HCI | HCI GROUP INC | NYSE | Insurance - Property & Casualty | A | $2.06B | $158.67 | -1.08% | $301.16M | 9.19x | 1.82 | United States | 50 |
| BLBD | BLUE BIRD CORP | NASDAQ | Auto Manufacturers | A | $1.60B | $50.31 | 1.43% | $194.43M | 12.55x | 1.45 | United States | 46 |
| TBLA | TABOOLACOM LTD | NASDAQ | Internet Content & Information | A | $1.15B | $4.00 | -2.91% | $137.29M | 50.00x | 0.68 | United States | 41 |
| SMP | STANDARD MOTOR PRODUCTS INC | NYSE | Auto Parts | A | $878.43M | $39.93 | -0.99% | $129.61M | 28.12x | 1.97 | United States | 42 |
| NRDS | NERDWALLET INC | NASDAQ | Internet Content & Information | A | $876.92M | $12.06 | -2.74% | $98.00M | 12.43x | 0.23 | United States | 47 |
| UVE | UNIVERSAL INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $854.09M | $30.45 | 0.30% | $174.52M | 6.95x | 5.24 | United States | 39 |
| PHR | PHREESIA INC | NYSE | Health Information Services | A | $809.65M | $13.43 | -3.73% | $25.66M | -134.30x | 0.32 | United States | 29 |
| BWMX | BETTERWARE DE MEXICO SAPI DE CV | NYSE | Specialty Retail | A | $670.21M | $17.96 | -0.72% | $145.14M | N/A | 6.80 | Mexico | 27 |
| EMBC | EMBECTA CORP | NASDAQ | Medical Instruments & Supplies | A | $620.82M | $10.61 | 3.01% | $294.70M | 6.47x | -2.68 | United States | 41 |
| LE | LANDS' END INC | NASDAQ | Apparel Retail | A | $542.59M | $17.76 | -1.39% | $86.84M | 48.00x | 2.69 | United States | 31 |
| ORGO | ORGANOGENESIS HOLDINGS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $507.65M | $4.00 | -0.25% | $18.04M | -33.33x | 0.49 | United States | 20 |
| ELMD | ELECTROMED INC | NYSEMKT | Medical Devices | A | $249.13M | $29.87 | 4.08% | $12.05M | 30.79x | 0.20 | United States | 51 |
| EGHT | 8X8 INC | NASDAQ | Software - Application | A | $230.14M | $1.66 | 1.22% | $51.06M | -41.50x | 4.04 | United States | 12 |
| OPRX | OPTIMIZERX CORP | NASDAQ | Health Information Services | A | $200.57M | $10.76 | -0.55% | $11.65M | N/A | 0.39 | United States | 27 |
| INFU | INFUSYSTEM HOLDINGS INC | NYSEMKT | Medical Instruments & Supplies | A | $167.98M | $8.26 | 2.61% | $24.16M | 31.77x | 0.78 | United States | 45 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.